Biblio

Found 10 results
Filters: Keyword is Animals and Author is Ronaldson, Patrick T  [Clear All Filters]
2022
Nilles KL, Williams EI, Betterton RD, Davis TP, Ronaldson PT.  2022.  Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke.. Int J Mol Sci. 23(3)
Betterton RD, Abdullahi W, Williams EI, Lochhead JJ, Brzica H, Stanton J, Reddell E, Ogbonnaya C, Davis TP, Ronaldson PT.  2022.  Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins).. Drug Metab Dispos. 50(7):942-956.
Stanton JA, Williams EI, Betterton RD, Davis TP, Ronaldson PT.  2022.  Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats.. Exp Neurol. 357:114181.
2018
Abdullahi W, Tripathi D, Ronaldson PT.  2018.  Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.. Am J Physiol Cell Physiol. 315(3):C343-C356.
2017
Abdullahi W, Brzica H, Ibbotson K, Davis TP, Ronaldson PT.  2017.  Bone morphogenetic protein-9 increases the functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier via the activin receptor-like kinase-1 receptor.. J Cereb Blood Flow Metab. 37(7):2340-2345.
Ibbotson K, Yell J, Ronaldson PT.  2017.  Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress.. Fluids Barriers CNS. 14(1):6.
2015
Ronaldson PT, Davis TP.  2015.  Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury.. Brain Res. 1623:39-52.
2014
Thompson BJ, Ronaldson PT.  2014.  Drug delivery to the ischemic brain.. Adv Pharmacol. 71:165-202.
Thompson BJ, Sanchez-Covarrubias L, Slosky LM, Zhang Y, Laracuente M-L, Ronaldson PT.  2014.  Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery.. J Cereb Blood Flow Metab. 34(4):699-707.
2012
Lochhead JJ, McCaffrey G, Sanchez-Covarrubias L, Finch JD, DeMarco KM, Quigley CE, Davis TP, Ronaldson PT.  2012.  Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain.. Am J Physiol Heart Circ Physiol. 302(3):H582-93.